Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 11,900 shares at an average $4.11 ($48,894)
  3. 4 Open-market buy Chief Executive Officer bought 18,400 shares at an average $4.36 ($80,228)
  4. 4 Open-market buy 10% owner bought 18,400 shares at an average $4.36 ($80,228)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy 10% owner bought 851,546 shares at $3.52 ($2,999,997)
  19. 4 Open-market buy 10% owner bought 851,546 shares at $3.52 ($2,999,997)
  20. 4 Open-market buy Director bought 28,384 shares at $3.52 ($99,997)

Page 11 of 18 · 345 filings